Vaccine Name | Composition | Primary type | Development phase |
---|---|---|---|
H1/IC31 | ESAT6-Ag85B fusion protein + IC31 adjuvant | Booster vaccine | Phase 1 |
HyVac4 | TB10.4-Ag85B fusion protein + IC31 adjuvant | Booster vaccine | Phase 1/2 |
ID93/GLA-SE | Rv2608-Rv3619-Rv3620-Rv1813 fusion protein + GLA-SE adjuvant | Booster vaccine | Phase 1 |
H56/IC31 | Ag85B-ESAT6-Rv2660c fusion protein + IC31 adjuvant | Booster vaccine | Phase1/2a |
M72/AS01E | Mtb39a-Mtb32a fusion protein + AS01E adjuvant | Booster vaccine | Phase 2 |